Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EPAS1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | CSTF3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ZBTB3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | IKZF5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | VIM | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ZNF77 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | MAPK1IP1L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | CENPO | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | MMP19 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | SMARCD1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |